Rafferty Asset Management’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $667K | Sell |
252,468
-72,081
| -22% | -$190K | ﹤0.01% | 829 |
|
|
2025
Q1 | $977K | Sell |
324,549
-225,356
| -41% | -$678K | ﹤0.01% | 746 |
|
|
2024
Q4 | $1.41M | Buy |
549,905
+94,200
| +21% | +$241K | 0.01% | 729 |
|
|
2024
Q3 | $1.7M | Buy |
455,705
+20,052
| +5% | +$74.6K | 0.01% | 675 |
|
|
2024
Q2 | $2.75M | Sell |
435,653
-874,737
| -67% | -$5.53M | 0.01% | 554 |
|
|
2024
Q1 | $7.04M | Buy |
1,310,390
+570,582
| +77% | +$3.06M | 0.03% | 378 |
|
|
2023
Q4 | $3.71M | Buy |
+739,808
| New | +$3.71M | 0.02% | 507 |
|
|
2023
Q1 | – | Sell |
-471,523
| Closed | -$2.39M | – | 1155 |
|
|
2022
Q4 | $2.39M | Buy |
471,523
+67,083
| +17% | +$340K | 0.02% | 527 |
|
|
2022
Q3 | $2.01M | Buy |
404,440
+120,118
| +42% | +$597K | 0.02% | 507 |
|
|
2022
Q2 | $1.06M | Sell |
284,322
-495,878
| -64% | -$1.85M | 0.01% | 625 |
|
|
2022
Q1 | $4.38M | Sell |
780,200
-45,188
| -5% | -$254K | 0.03% | 417 |
|
|
2021
Q4 | $5.02M | Buy |
825,388
+374,349
| +83% | +$2.28M | 0.03% | 388 |
|
|
2021
Q3 | $4.39M | Buy |
451,039
+33,261
| +8% | +$324K | 0.03% | 330 |
|
|
2021
Q2 | $5.97M | Sell |
417,778
-107,506
| -20% | -$1.54M | 0.04% | 276 |
|
|
2021
Q1 | $12.5M | Buy |
525,284
+465,195
| +774% | +$11M | 0.09% | 141 |
|
|
2020
Q4 | $801K | Buy |
+60,089
| New | +$801K | 0.01% | 571 |
|